Hence, upregulation of RNCR3 level seems as a novel therapeutic strategy to protect against hypercholesterolemia-induced EC and VSMC dysfunction and atherosclerosis development. The gene discussed is MIR124-1HG; the disease is familial hypercholesterolemia.